Raquel Izumi
Founder at VINCERX PHARMA, INC.
Net worth: 2 M $ as of 29/04/2024
Raquel Izumi active positions
Companies | Position | Start | End |
---|---|---|---|
VINCERX PHARMA, INC. | Director/Board Member | 22/12/2020 | - |
Chief Operating Officer | 22/12/2020 | - | |
Founder | 18/12/2018 | - | |
President | 05/01/2021 | - | |
Corporate Secretary | 22/12/2020 | - | |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Director/Board Member | - | - |
Independent Dir/Board Member | - | - |
Career history of Raquel Izumi
Former positions of Raquel Izumi
Companies | Position | Start | End |
---|---|---|---|
Vincera Pharma, Inc. /Old/
Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Vincera Pharma, Inc. operates as a biopharmaceutical company. It develops and delivers medicines to patients. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd and is headquartered in Santa Clara, CA. | Director/Board Member | - | 30/11/2020 |
Chief Operating Officer | - | 28/02/2019 | |
Founder | - | 30/11/2020 | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Founder | 31/01/2013 | 30/04/2020 |
Corporate Officer/Principal | 31/01/2013 | 30/04/2020 | |
Aspire Therapeutics LLC | Chief Tech/Sci/R&D Officer | 31/05/2011 | 31/01/2013 |
Founder | 31/05/2011 | 31/01/2013 | |
PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 31/01/2010 | 30/04/2011 |
Training of Raquel Izumi
University of California, Los Angeles | Doctorate Degree |
University of California, Santa Barbara | Undergraduate Degree |
Statistics
International
United States | 8 |
Netherlands | 2 |
Operational
Founder | 4 |
Director/Board Member | 3 |
Chief Operating Officer | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VINCERX PHARMA, INC. | Health Technology |
Private companies | 5 |
---|---|
Vincera Pharma, Inc. /Old/
Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Vincera Pharma, Inc. operates as a biopharmaceutical company. It develops and delivers medicines to patients. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd and is headquartered in Santa Clara, CA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Aspire Therapeutics LLC | |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Finance |
- Stock Market
- Insiders
- Raquel Izumi
- Experience